Overall increase is small, though, adding 1 cancer per 1,000 women treated
by yrles1 on Mon Feb 21, 2011 02:18 PM
Has anyone investigated BC-819 aka DTA-H19 as a treatment option for Pancreatic Cancer? I have studied the trials, and they have met with good success. It is my understanding BC-819 has been given Orphan drug status, and is already approved for compassionate use in other cancers.
A clinical trial request for the combo of BC-819/Gemzar will be requested. I have yet to find out when that will take place. I am interested in knowing the in's & out's of off label/and compassionate use for this product and have contacted the maker (Biocancell). Hoping for a response. They are working with The Massey Cancer Center, and the University of Maryland.
Any futher info would be greatly appreciated!
When you track a discussion, you will get notified by e-mail if anyone else posts a new message on this discussion. Are you sure you want to track this discussion?
If you stop tracking this discussion, you will no longer get notified by e-mail if anyone else posts a new message on this discussion. Are you sure you want to stop tracking this discussion?
If you were considering traveling for cancer treatment, which headline would you find more interesting?
Destination: HOPE. Cancer care that is worth the trip.
Over 84% of our patients travel to our hospital from another state
Neither headline is interesting
We care about your feedback. Let us know how we can improve your CancerCompass experience.